NCT03961529View on ClinicalTrials.gov

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

November 11, 2020

Study Completion Date

November 11, 2020

Conditions
Atopic Dermatitis
Interventions
DRUG

0.3% OPA-15406 ointment

Twice daily

DRUG

1% OPA-15406 ointment

Twice daily

Trial Locations (1)

Unknown

Shirao clinic of pediatrics and pediatric allergy, Hiroshima

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY